Press release
Comprehensive Subcutaneous Immunoglobulin (SCIG) Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034
Subcutaneous Immunoglobulin (SCIG)
The rise in secondary immunodeficiency diseases is expected to drive the growth of the subcutaneous immunoglobulin market. Secondary immunodeficiency diseases, caused by factors such as aging populations and immunosuppressive treatments, reduce immune function. Subcutaneous immunoglobulin therapy helps strengthen the immune system by providing necessary antibodies. The UK Health Security Agency reported in October 2023 that new HIV diagnoses in England increased by 22% in 2022, which will support the subcutaneous immunoglobulin market.
Get Your Subcutaneous Immunoglobulin (SCIG) Market Report Here:
https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report
What Is the projected market size and growth rate for the subcutaneous immunoglobulin (scig) market?
The subcutaneous immunoglobulin (SCIG) market has seen rapid growth and is expected to rise from $12.72 billion in 2024 to $14.52 billion in 2025, with a CAGR of 14.1%. This growth is driven by the rising prevalence of immunodeficiency disorders, patient preference for home-based care, better therapeutic effectiveness, increased awareness, and favorable reimbursement policies.
The subcutaneous immunoglobulin (SCIG) market is projected to reach $24.29 billion by 2029, growing at a CAGR of 13.7%. Growth is driven by the rising prevalence of neurological and autoimmune disorders, greater acceptance of immunoglobulin therapy, expanding applications in neurology and dermatology, and increasing healthcare facilities. Key trends include advancements in drug delivery systems, home infusion therapy demand, antibody therapy innovations, and SCIG formulation improvements.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15935&type=smp
What new trends are reshaping the subcutaneous immunoglobulin (scig) market and its opportunities?
In the subcutaneous immunoglobulin market, companies are developing unique formulations like subcutaneous human-klhw to strengthen the immune system. For instance, in March 2022, Grifols launched XEMBIFY 20% subcutaneous immunoglobulin (SCIG), designed to treat primary immunodeficiency diseases. This formulation is stable at room temperature for up to 24 months, simplifying treatment and improving patient convenience by avoiding refrigeration during storage and transport.
What major market segments define the scope and growth of the subcutaneous immunoglobulin (scig) market?
The subcutaneous immunoglobulin (SCIG) market covered in this report is segmented -
1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications
3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses
Subsegments:
1) By Immunoglobulin A (IgA): IgA1, IgA2
2) By Immunoglobulin G (IgG): IgG1, IgG2, IgG3, IgG4
3) By Immunoglobulin M (IgM): Pentameric IgM, Hexameric IgM
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15935
Which regions are key players in the growth of the subcutaneous immunoglobulin (scig) market?
North America was the largest region in the subcutaneous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which key market leaders are driving the subcutaneous immunoglobulin (scig) industry growth?
Major companies operating in the subcutaneous immunoglobulin (SCIG) market are Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Baxter International Inc., CSL Behring, Lonza Group, Grifols S.A., Octapharma AG, Dr. Reddy's Laboratories, Intas pharmaceutical Ltd., Emergent BioSolutions Inc., Kedrion Biopharma, LFB group, Biotest AG, Argenx SE, Bio Products Laboratory Ltd., ADMA Biologics Inc., Sino Biological Inc., Bharat Serums and Vaccines Limited (BSV), Kamada Pharmaceuticals, CinnaGen Co., Shire plc
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15935&type=smp
What Is Covered In The Subcutaneous Immunoglobulin (SCIG) Global Market Report?
•Market Size Forecast: Examine the subcutaneous immunoglobulin (scig) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the subcutaneous immunoglobulin (scig) market for a structured understanding.
•Key Players Overview: Analyze major players in the subcutaneous immunoglobulin (scig) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the subcutaneous immunoglobulin (scig) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the subcutaneous immunoglobulin (scig) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the subcutaneous immunoglobulin (scig) market.
•Industry Challenges: Identify potential risks and obstacles affecting the subcutaneous immunoglobulin (scig) market.
•Competitive Landscape: Review strategic developments in the subcutaneous immunoglobulin (scig) market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Subcutaneous Immunoglobulin (SCIG) Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034 here
News-ID: 3936235 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for SCIG
Leading Companies Reinforce Their Presence in the Subcutaneous Immunoglobulin (S …
The subcutaneous immunoglobulin (SCIG) market is poised for significant expansion in the coming years, driven by various healthcare advancements and increasing demand. This report takes a detailed look at the market's value projections, key players, emerging trends, and the main segments propelling growth in this vital medical field.
Market Size Outlook and Growth Drivers for the Subcutaneous Immunoglobulin (SCIG) Market
The SCIG market is expected to experience rapid growth, reaching…
Subcutaneous Immunoglobulin (SCIG) Market: Major Trends Reshaping the Future of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Subcutaneous Immunoglobulin (SCIG) Industry Market Size Be by 2025?
Recent years have seen a swift expansion of the subcutaneous immunoglobulin (SCIG) market. The market, which stood at $12.72 billion in 2024, is projected to rise to $14.52 billion by 2025, reflecting a compound annual growth rate…
Subcutaneous Immunoglobulin (SCIG) Market Forecast 2025-2034: Comprehensive Anal …
The Subcutaneous Immunoglobulin (SCIG) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Subcutaneous Immunoglobulin (SCIG) Market?
The subcutaneous immunoglobulin (SCIG) market has grown rapidly in recent years. It is expected to rise from $12.72 billion in 2024 to $14.52…
Boosting Immunity: Innovations in Subcutaneous Immunoglobulin (SCIG)
The Business Research Company recently released a comprehensive report on the Global Subcutaneous Immunoglobulin (SCIG) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your…
Subcutaneous Immunoglobulin (SCIg) Market - Global Industry Analysis, Size, Shar …
Immunoglobulin, commonly known as an antibody, is a Y-shaped protein manufactured primarily by plasma cells. Immunoglobulin is utilized by the immune system to counterbalance pathogens. Subcutaneous injections are administered as vaccines and medications including insulin and immunoglobulin. The process of administering immunoglobulin is known as immunoglobulin therapy. When immunoglobulin therapy is applied below the dermis and epidermis, or cutis, it is known as subcutaneous immunoglobulin. Subcutaneous therapy is useful as…
Subcutaneous Immunoglobulin (SCIg) Market Size, Status and Forecast 2024
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size.
Immunoglobulin replacement therapy (IRT) is the systematic care for patients with antibody deficit. Immunoglobulin replacement therapy can be of two types: subcutaneous immunoglobulin (SCIg) and intravenous immunoglobulin (IVIg). The choice of treatment depends upon numerous factors such as clinical symptoms, patient physiognomies, intravenous access, and possible side…
